Literature DB >> 2179716

Isolation and studies of the mutagenic activity in the Ames test of flavonoids naturally occurring in medical herbs.

H Czeczot1, B Tudek, J Kusztelak, T Szymczyk, B Dobrowolska, G Glinkowska, J Malinowski, H Strzelecka.   

Abstract

Quercetin, rhamnetin, isohamnetin, apigenin and luteolin were isolated from medicinal herbs: Erigeron canadensis L., Anthyllis vulneraria L. and Pyrola chloranta L. The mutagenicity of these naturally occurring flavonoids was tested by the Ames method with S. typhimurium strains TA1535, TA1538, TA97, TA98, TA100 and TA102 in the presence and absence of metabolic activation. Of the above flavonoids only quercetin and rhamnetin revealed mutagenic activity in the Ames test. Quercetin induced point mutations in strains TA97, TA98, TA100 and TA102 of S. typhimurium. The presence of S9 rat liver microsome fraction markedly enhanced the mutagenic activity of quercetin in these strains. Rhamnetin appeared to be a much weaker mutagen in the Ames test. The compound induced mutations in strains TA97, TA98 and TA100 of S. typhimurium but only in the presence of metabolic activation. Comparison of the structure of the studied flavonoids with their mutagenic activity indicates that the mutagenicity of flavonoids is dependent on the presence of hydroxyl groups in the 3' and 4' positions of the B ring, and that the presence of a free hydroxy or methoxy group in the 7 position of the A ring also probably contributes to the appearance of mutagenic activity of flavonoids in the Ames test. It also appeared that the presence of methoxy groups, particularly in the B ring of the flavonoid molecule, markedly decreases the mutagenic activity of the compound.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2179716     DOI: 10.1016/0165-1218(90)90060-f

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  25 in total

1.  Preclinical colorectal cancer chemopreventive efficacy and p53-modulating activity of 3',4',5'-trimethoxyflavonol, a quercetin analogue.

Authors:  Lynne M Howells; Robert G Britton; Marco Mazzoletti; Peter Greaves; Massimo Broggini; Karen Brown; William P Steward; Andreas J Gescher; Stewart Sale
Journal:  Cancer Prev Res (Phila)       Date:  2010-07-13

Review 2.  Targeting the PI3K/Akt/mTOR axis by apigenin for cancer prevention.

Authors:  Xin Tong; Jill C Pelling
Journal:  Anticancer Agents Med Chem       Date:  2013-09       Impact factor: 2.505

3.  Suppression by apigenin of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane in Wistar rats.

Authors:  A Tatsuta; H Iishi; M Baba; H Yano; K Murata; M Mukai; H Akedo
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

4.  Phytotoxicity and cytogenotoxicity of hydroalcoholic extracts from Solanum muricatum Ait. and Solanum betaceum Cav. (Solanaceae) in the plant model Lactuca sativa.

Authors:  Fabio Eduardo Dos Santos; Marcos Schleiden Sousa Carvalho; Graciele Lurdes Silveira; Felipe Folgaroli Correa; Maria das Graças Cardoso; Larissa Fonseca Andrade-Vieira; Luciane Resende Vilela
Journal:  Environ Sci Pollut Res Int       Date:  2018-03-05       Impact factor: 4.223

5.  Apigenin prevents UVB-induced cyclooxygenase 2 expression: coupled mRNA stabilization and translational inhibition.

Authors:  Xin Tong; Rukiyah T Van Dross; Adnan Abu-Yousif; Aubrey R Morrison; Jill C Pelling
Journal:  Mol Cell Biol       Date:  2006-10-30       Impact factor: 4.272

6.  Sub-toxic dose of apigenin sensitizes HepG2 cells to TRAIL through ERK-dependent up-regulation of TRAIL receptor DR5.

Authors:  Eun Young Kim; Ji Sun Yu; Mihi Yang; An Keun Kim
Journal:  Mol Cells       Date:  2012-12-04       Impact factor: 5.034

7.  Enhancement of p53 expression in keratinocytes by the bioflavonoid apigenin is associated with RNA-binding protein HuR.

Authors:  Xin Tong; Jill C Pelling
Journal:  Mol Carcinog       Date:  2009-02       Impact factor: 4.784

8.  Apigenin induces apoptosis via downregulation of S-phase kinase-associated protein 2-mediated induction of p27Kip1 in primary effusion lymphoma cells.

Authors:  A R Hussain; A S Khan; S O Ahmed; M Ahmed; L C Platanias; K S Al-Kuraya; S Uddin
Journal:  Cell Prolif       Date:  2010-01-14       Impact factor: 6.831

9.  Combination of apigenin treatment with therapeutic HPV DNA vaccination generates enhanced therapeutic antitumor effects.

Authors:  Chi-Mu Chuang; Archana Monie; Annie Wu; Chien-Fu Hung
Journal:  J Biomed Sci       Date:  2009-05-27       Impact factor: 8.410

10.  Apigenin promotes apoptosis, inhibits invasion and induces cell cycle arrest of T24 human bladder cancer cells.

Authors:  Yi Zhu; Yeqing Mao; Hong Chen; Yiwei Lin; Zhenghui Hu; Jian Wu; Xin Xu; Xianglai Xu; Jie Qin; Liping Xie
Journal:  Cancer Cell Int       Date:  2013-06-01       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.